Cure8 research brief
Why This Matters
Capsule endoscopy can be helpful for small-bowel assessment in Crohn’s disease but carries a risk of retention when strictures are present. Retained capsules may be asymptomatic yet still require surgery, so better pre-procedure screening can reduce that risk.
Who Should Pay Attention
Patients with Crohn’s disease (particularly with known or suspected strictures); gastroenterologists and colorectal surgeons; care teams ordering capsule endoscopy.
Study Snapshot
What To Know
These two case reports describe asymptomatic capsule endoscopy retention in patients with established Crohn’s disease where cross-sectional imaging did not predict significant small-bowel stenosis.
In both patients the retained capsule was confirmed radiologically after about 2 weeks, corticosteroid treatment did not lead to passage, and surgery (resection or stricturoplasty) was required to retrieve the capsule and treat the strictures.
The reports emphasize pre-procedure risk stratification: use cross-sectional imaging routinely and consider patency capsule testing when available for patients at risk of small-bowel stenosis. Multidisciplinary planning is important because retained capsules can be clinically silent yet require surgical management.
These are surgical case reports summarizing individual patient courses; they do not provide comparative outcomes or rates of retention.
Keep In Mind
Structured content depth is abstract from the Journal of Surgical Case Reports. These are two individual case reports and do not provide generalizable rates or comparative effectiveness data. Patency capsule testing availability and cross-sectional imaging accuracy vary by center.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.